(VIANEWS) – Another day of trading has ended and here’s today’s list of stocks that have had significant trading activity in the US session.
The three biggest winners today are Arcturus Therapeutics, Precision Drilling Corporation, and Natuzzi, S.p.A..
| Rank | Financial Asset | Price | Change | Updated (EST) |
|---|---|---|---|---|
| 1 | Arcturus Therapeutics (ARCT) | 34.97 | 13.5% | 2023-07-14 13:06:38 |
| 2 | Precision Drilling Corporation (PDS) | 55.06 | 5.26% | 2023-07-14 03:47:07 |
| 3 | Natuzzi, S.p.A. (NTZ) | 6.95 | 4.51% | 2023-07-13 22:23:08 |
| 4 | Cigna (CI) | 282.14 | 4.47% | 2023-07-14 13:10:39 |
| 5 | Cigna (CI) | 282.14 | 4.47% | 2023-07-14 13:10:39 |
| 6 | Owens & Minor (OMI) | 19.10 | 3.35% | 2023-07-14 01:10:08 |
| 7 | Genmab (GMAB) | 40.01 | 3.28% | 2023-07-14 13:07:28 |
| 8 | Natural Resource Partners LP Limited Partnership (NRP) | 54.74 | 3.15% | 2023-07-13 21:12:10 |
| 9 | Eli Lilly and Company (LLY) | 448.13 | 3.09% | 2023-07-14 13:42:26 |
| 10 | VerifyMe (VRME) | 1.37 | 3.01% | 2023-07-14 10:37:26 |
The three biggest losers today are Canopy Growth, Ericsson, and State Street Corporation.
| Rank | Financial Asset | Price | Change | Updated (EST) |
|---|---|---|---|---|
| 1 | Canopy Growth (CGC) | 0.40 | -38.25% | 2023-07-14 12:53:03 |
| 2 | Ericsson (ERIC) | 5.06 | -11.85% | 2023-07-14 13:35:30 |
| 3 | State Street Corporation (STT) | 69.16 | -10.72% | 2023-07-14 13:14:22 |
| 4 | SmileDirectClub (SDC) | 0.70 | -9.76% | 2023-07-14 12:16:37 |
| 5 | Lumen Technologies (LUMN) | 1.87 | -9.47% | 2023-07-14 13:47:52 |
| 6 | Nokia (NOK) | 3.96 | -9.08% | 2023-07-14 13:43:20 |
| 7 | Tilray (TLRY) | 1.66 | -8.56% | 2023-07-14 12:31:35 |
| 8 | Peloton (PTON) | 8.80 | -8.39% | 2023-07-14 13:08:08 |
| 9 | Canaan (CAN) | 2.95 | -7.22% | 2023-07-14 13:06:57 |
| 10 | Virgin Galactic (SPCE) | 3.76 | -6.47% | 2023-07-14 13:47:19 |
Winners today
1. Arcturus Therapeutics (ARCT) – 13.5%
Arcturus Therapeutics Holdings Inc., a late-stage clinical messenger RNA medicines and vaccine company, focuses on the development of infectious disease vaccines and other products within liver and respiratory rare diseases. Its technology platforms include LUNAR lipid-mediated delivery and STARR mRNA. The company is developing ARCT-810 (LUNAR-OTC), a mRNA-based therapeutic candidate, which is in Phase 2 clinical trial for treating ornithine transcarbamylase deficiency; and ARCT-154 (LUNAR-COV19), a mRNA vaccine candidate that is in Phase 3 arm of a Phase 1/2/3 study in Vietnam for the treatment of COVID-19, as well as ARCT-032 (LUNAR-CF), a mRNA therapeutic candidate for cystic fibrosis. The company was founded in 2013 and is headquartered in San Diego, California.
NASDAQ ended the session with Arcturus Therapeutics jumping 13.5% to $34.97 on Friday, following the last session’s downward trend. NASDAQ dropped 0.18% to $14,113.70, after four sequential sessions in a row of gains, on what was a somewhat negative trend exchanging session today.
Earnings Per Share
As for profitability, Arcturus Therapeutics has a trailing twelve months EPS of $4.12.
PE Ratio
Arcturus Therapeutics has a trailing twelve months price to earnings ratio of 8.49. Meaning, the purchaser of the share is investing $8.49 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 43.3%.
Volume
Today’s last reported volume for Arcturus Therapeutics is 983374 which is 136.82% above its average volume of 415226.
Volatility
Arcturus Therapeutics’s last week, last month’s, and last quarter’s current intraday variation average was 1.86%, 0.66%, and 2.70%.
Arcturus Therapeutics’s highest amplitude of average volatility was 4.11% (last week), 2.79% (last month), and 2.70% (last quarter).
Sales Growth
Arcturus Therapeutics’s sales growth is 64.2% for the present quarter and 455% for the next.
More news about Arcturus Therapeutics.
2. Precision Drilling Corporation (PDS) – 5.26%
Precision Drilling Corporation, an oilfield services company, provides oil and natural gas drilling and related services and products. The company operates in two segments, Contract Drilling Services, and Completion and Production Services. The Contract Drilling Services segment offers onshore well drilling services to exploration and production companies in the oil and natural gas industry. This segment provides land drilling, directional drilling, and turnkey drilling services; and procures and distributes oilfield supplies, as well as manufactures and refurbishes drilling and service rig equipment. As of December 31, 2019, this segment operated 226 land drilling rigs, including 109 in Canada; 104 in the United States; 6 in Kuwai; 4 in Saudi Arabia; 2 in the Kurdistan region of Iraq; and 1 in the country of Georgia. The Completion and Production Services segment provides service rigs for well completion, workover, abandonment, maintenance, and re-entry preparation services; wellsite accommodations; and oilfield surface equipment rentals, as well as pressure control services to oil and natural gas exploration and production companies. As of December 31, 2019, this segment operated 123 well completion and workover service rigs, including 114 in Canada; 9 in the United States; approximately 1,700 oilfield rental items, including surface storage, small-flow wastewater treatment, and power generation and solids control equipment; and 132 wellsite accommodation units in Canada. It also had 42 drilling camps in Canada. Precision Drilling Corporation was incorporated in 1951 and is headquartered in Calgary, Canada.
NYSE ended the session with Precision Drilling Corporation rising 5.26% to $55.06 on Friday, after three sequential sessions in a row of gains. NYSE fell 0.41% to $16,040.23, after five sequential sessions in a row of gains, on what was a somewhat negative trend trading session today.
Earnings Per Share
As for profitability, Precision Drilling Corporation has a trailing twelve months EPS of $4.83.
PE Ratio
Precision Drilling Corporation has a trailing twelve months price to earnings ratio of 11.4. Meaning, the purchaser of the share is investing $11.4 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 8.32%.
More news about Precision Drilling Corporation.
3. Natuzzi, S.p.A. (NTZ) – 4.51%
Natuzzi S.p.A. designs, manufactures, and markets leather and fabric upholstered furniture through its own and franchised stores worldwide. The company operates through Natuzzi Brand and Private Label segments. Its products primarily include stationary furniture, such as sofas, loveseats, and armchairs; sectional furniture; motion furniture; sofa beds; occasional chairs, including recliners and massage chairs; and home furnishing accessories, including coffee tables, lamps, rugs, and wall units. The company also sells polyurethane foam and leather by-products. As of March 31, 2020, it operated 237 Natuzzi Italia stores; 69 Divani&Divani by Natuzzi stores; and 249 Natuzzi Editions stores. The company was formerly known as Industrie Natuzzi S.p.A. and changed its name to Natuzzi S.p.A. in June 2002. Natuzzi S.p.A. was founded in 1959 and is headquartered in Santeramo in Colle, Italy.
NYSE ended the session with Natuzzi, S.p.A. jumping 4.51% to $6.95 on Friday while NYSE slid 0.41% to $16,040.23.
Earnings Per Share
As for profitability, Natuzzi, S.p.A. has a trailing twelve months EPS of $-0.46.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -3.69%.
Volume
Today’s last reported volume for Natuzzi, S.p.A. is 429 which is 89.33% below its average volume of 4024.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Natuzzi, S.p.A.’s EBITDA is -109.82.
Yearly Top and Bottom Value
Natuzzi, S.p.A.’s stock is valued at $6.95 at 17:33 EST, way under its 52-week high of $10.74 and way higher than its 52-week low of $4.40.
More news about Natuzzi, S.p.A..
4. Cigna (CI) – 4.47%
The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers. The company's Cigna Healthcare segment offers medical, pharmacy, behavioral health, dental, and other products and services for insured and self-insured customers; Medicare Advantage, Medicare Supplement, and Medicare Part D plans for seniors, as well as individual health insurance plans; and health care coverage in its international markets, as well as health care benefits for mobile individuals and employees of multinational organizations. The company also offers permanent insurance contracts sold to corporations to provide coverage on the lives of certain employees for financing employer-paid future benefit obligations. It distributes its products and services through insurance brokers and consultants; directly to employers, unions and other groups, or individuals; and private and public exchanges. The company was formerly known as Cigna Corporation and changed its name to The Cigna Group in February 2023. The Cigna Group was founded in 1792 and is headquartered in Bloomfield, Connecticut.
NYSE ended the session with Cigna rising 4.47% to $282.14 on Friday while NYSE dropped 0.41% to $16,040.23.
Earnings Per Share
As for profitability, Cigna has a trailing twelve months EPS of $21.82.
PE Ratio
Cigna has a trailing twelve months price to earnings ratio of 12.93. Meaning, the purchaser of the share is investing $12.93 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 15.07%.
Moving Average
Cigna’s worth is higher than its 50-day moving average of $262.15 and under its 200-day moving average of $288.96.
Dividend Yield
As claimed by Morningstar, Inc., the next dividend payment is on Jun 5, 2023, the estimated forward annual dividend rate is 4.92 and the estimated forward annual dividend yield is 1.77%.
Sales Growth
Cigna’s sales growth is 3.8% for the ongoing quarter and 6.5% for the next.
More news about Cigna.
5. Cigna (CI) – 4.47%
The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers. The company's Cigna Healthcare segment offers medical, pharmacy, behavioral health, dental, and other products and services for insured and self-insured customers; Medicare Advantage, Medicare Supplement, and Medicare Part D plans for seniors, as well as individual health insurance plans; and health care coverage in its international markets, as well as health care benefits for mobile individuals and employees of multinational organizations. The company also offers permanent insurance contracts sold to corporations to provide coverage on the lives of certain employees for financing employer-paid future benefit obligations. It distributes its products and services through insurance brokers and consultants; directly to employers, unions and other groups, or individuals; and private and public exchanges. The company was formerly known as Cigna Corporation and changed its name to The Cigna Group in February 2023. The Cigna Group was founded in 1792 and is headquartered in Bloomfield, Connecticut.
NYSE ended the session with Cigna rising 4.47% to $282.14 on Friday, following the last session’s upward trend. NYSE dropped 0.41% to $16,040.23, after five consecutive sessions in a row of gains, on what was a somewhat bearish trend exchanging session today.
Earnings Per Share
As for profitability, Cigna has a trailing twelve months EPS of $21.82.
PE Ratio
Cigna has a trailing twelve months price to earnings ratio of 12.93. Meaning, the purchaser of the share is investing $12.93 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 15.07%.
Moving Average
Cigna’s worth is above its 50-day moving average of $262.15 and below its 200-day moving average of $288.96.
Yearly Top and Bottom Value
Cigna’s stock is valued at $282.14 at 17:33 EST, way below its 52-week high of $340.11 and way higher than its 52-week low of $240.50.
Sales Growth
Cigna’s sales growth is 3.8% for the ongoing quarter and 6.5% for the next.
Dividend Yield
As maintained by Morningstar, Inc., the next dividend payment is on Jun 5, 2023, the estimated forward annual dividend rate is 4.92 and the estimated forward annual dividend yield is 1.77%.
More news about Cigna.
6. Owens & Minor (OMI) – 3.35%
Owens & Minor, Inc., together with its subsidiaries, operates as a healthcare solutions company in the United States and internationally. It operates through two segments, Global Solutions and Global Products. The Global Solutions segment offers a portfolio of products and services to healthcare providers and manufacturers. Its portfolio of medical and surgical supplies includes branded products and its proprietary products. This segment also offers services to healthcare providers, which include supplier management, analytics, inventory management, and clinical supply management; and various programs to provide logistics and marketing solutions to its suppliers. The Global Products segment manufactures and sources medical surgical products for the prevention of healthcare-associated infections across the acute and alternate site channels. This segments products portfolio includes sterilization wraps, surgical drapes and gowns, facial protection products, protective apparel, medical exam gloves, custom and minor procedure kits, and other medical products. The company provides its products and services to multi-facility networks of healthcare providers, independent hospitals, surgery centers, physicians' practices, and networks of hospitals directly, as well as indirectly through third-party distributors. Owens & Minor, Inc. was founded in 1882 and is headquartered in Richmond, Virginia.
NYSE ended the session with Owens & Minor rising 3.35% to $19.10 on Friday, after four consecutive sessions in a row of gains. NYSE dropped 0.41% to $16,040.23, after five sequential sessions in a row of gains, on what was a somewhat down trend trading session today.
Earnings Per Share
As for profitability, Owens & Minor has a trailing twelve months EPS of $-0.57.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -4.41%.
Moving Average
Owens & Minor’s worth is higher than its 50-day moving average of $19.06 and above its 200-day moving average of $18.58.
Revenue Growth
Year-on-year quarterly revenue growth grew by 4.8%, now sitting on 10.07B for the twelve trailing months.
More news about Owens & Minor.
7. Genmab (GMAB) – 3.28%
Genmab A/S develops antibody therapeutics for the treatment of cancer and other diseases primarily in Denmark. The company markets DARZALEX, a human monoclonal antibody for the treatment of patients with multiple myeloma (MM); teprotumumab for the treatment of thyroid eye disease; ofatumurnab, a human monoclonal antibody to treat chronic lymphocytic leukemia (CLL) and multiple sclerosis; and Amivantamab for advanced or metastatic gastric or esophageal cancer and NSCLC. Its products include daratumumab to treat MM, non-MM blood cancers, and AL amyloidosis; GEN1047; tisotumab vedotin for treating cervical, ovarian, and solid cancers; DuoBody-PD-L1x4-1BB, and DuoBody-CD40x4-1BB for treating solid tumors; Epcoritamab for relapsed/refractory diffuse large B-cell lymphoma and chronic lymphocytic leukemia; and HexaBody-CD38 and DuoHexaBody-CD37 for treating hematological malignancies. The company also develops Teclistamab, which is in Phase 2 trial for vaso-occlusive crises; Camidanlumab tesirine to treat hodgkin lymphoma and solid tumors; JNJ-64007957 and JNJ-64407564 to treat MM; PRV-015 for treating celiac disease; Mim8 for treating haemophilia A; and Lu AF82422 for treating multiple system atrophy disease. In addition, it has approximately 20 active pre-clinical programs. The company has a commercial license and collaboration agreement with Seagen Inc. to co-develop tisotumab vedotin. It also has a collaboration agreement with CureVac AG for the research and development of differentiated mRNA-based antibody products; argenx to discover, develop, and commercialize novel therapeutic antibodies with applications in immunology and oncology; and AbbVie for the development of epcoritamab, as well as collaborations with BioNTech, Janssen, Novo Nordisk A/S, BliNK Biomedical SAS, and Bolt Biotherapeutics, Inc. Genmab A/S was founded in 1999 and is headquartered in Copenhagen, Denmark.
NASDAQ ended the session with Genmab rising 3.28% to $40.01 on Friday while NASDAQ fell 0.18% to $14,113.70.
Earnings Per Share
As for profitability, Genmab has a trailing twelve months EPS of $1.2.
PE Ratio
Genmab has a trailing twelve months price to earnings ratio of 33.34. Meaning, the purchaser of the share is investing $33.34 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 21.17%.
Yearly Top and Bottom Value
Genmab’s stock is valued at $40.01 at 17:33 EST, way under its 52-week high of $47.50 and way higher than its 52-week low of $31.40.
Growth Estimates Quarters
The company’s growth estimates for the current quarter and the next is 429.3% and 271.7%, respectively.
More news about Genmab.
8. Natural Resource Partners LP Limited Partnership (NRP) – 3.15%
Natural Resource Partners L.P., through its subsidiaries, owns, manages, and leases a portfolio of mineral properties in the United States. It operates in two segments, Coal Royalty and Other, and Soda Ash. The company owns interests in coal, soda ash, trona, and other natural resources. Its coal reserves are primarily located in Appalachia, the Illinois Basin, and the Northern Powder River Basin in the United States; aggregates and industrial minerals are located in the United States; oil and gas royalty assets located in Louisiana; timber assets located in West Virginia; and trona ore mining operation and soda ash refinery located in the Green River Basin, Wyoming. The company leases a portion of its reserves in exchange for royalty payments; and owns transportation and processing infrastructure related to coal properties. NRP (GP) LP serves as the general partner of the company. Natural Resource Partners L.P. was founded in 2002 and is headquartered in Houston, Texas.
NYSE ended the session with Natural Resource Partners LP Limited Partnership jumping 3.15% to $54.74 on Friday while NYSE slid 0.41% to $16,040.23.
Earnings Per Share
As for profitability, Natural Resource Partners LP Limited Partnership has a trailing twelve months EPS of $13.91.
PE Ratio
Natural Resource Partners LP Limited Partnership has a trailing twelve months price to earnings ratio of 3.94. Meaning, the purchaser of the share is investing $3.94 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 52.75%.
Yearly Top and Bottom Value
Natural Resource Partners LP Limited Partnership’s stock is valued at $54.74 at 17:33 EST, way below its 52-week high of $65.72 and way higher than its 52-week low of $37.61.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Natural Resource Partners LP Limited Partnership’s EBITDA is 9.15.
Revenue Growth
Year-on-year quarterly revenue growth grew by 6.7%, now sitting on 333.08M for the twelve trailing months.
Moving Average
Natural Resource Partners LP Limited Partnership’s worth is above its 50-day moving average of $49.85 and way higher than its 200-day moving average of $49.15.
More news about Natural Resource Partners LP Limited Partnership.
9. Eli Lilly and Company (LLY) – 3.09%
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, Trajenta, and Trulicity for type 2 diabetes. The company provides Alimta for non-small cell lung cancer (NSCLC) and malignant pleural mesothelioma; Cyramza for metastatic gastric cancer, gastro-esophageal junction adenocarcinoma, metastatic NSCLC, metastatic colorectal cancer, and hepatocellular carcinoma; Erbitux for colorectal cancers, and various head and neck cancers; Retevmo for metastatic NSCLC, medullary thyroid cancer, and thyroid cancer; Tyvyt for relapsed or refractory classic Hodgkin's lymph and non-squamous NSCLC; and Verzenio for HR+, HER2- metastatic breast cancer, node positive, and early breast cancer. It offers Olumiant for rheumatoid arthritis; and Taltz for plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, and non-radiographic axial spondylarthritis. The company offers Cymbalta for depressive disorder, diabetic peripheral neuropathic pain, generalized anxiety disorder, fibromyalgia, and chronic musculoskeletal pain; Emgality for migraine prevention and episodic cluster headache; and Zyprexa for schizophrenia, bipolar I disorder, and bipolar maintenance. Its Bamlanivimab and etesevimab, and Bebtelovimab for COVID-19; Cialis for erectile dysfunction and benign prostatic hyperplasia; and Forteo for osteoporosis. The company has collaborations with Incyte Corporation; Boehringer Ingelheim Pharmaceuticals, Inc.; AbCellera Biologics Inc.; Junshi Biosciences; Regor Therapeutics Group; Lycia Therapeutics, Inc.; Kumquat Biosciences Inc.; Entos Pharmaceuticals Inc.; and Foghorn Therapeutics Inc. Eli Lilly and Company was founded in 1876 and is headquartered in Indianapolis, Indiana.
NYSE ended the session with Eli Lilly and Company rising 3.09% to $448.13 on Friday, following the last session’s downward trend. NYSE dropped 0.41% to $16,040.23, after five sequential sessions in a row of gains, on what was a somewhat down trend exchanging session today.
Earnings Per Share
As for profitability, Eli Lilly and Company has a trailing twelve months EPS of $6.3.
PE Ratio
Eli Lilly and Company has a trailing twelve months price to earnings ratio of 71.13. Meaning, the purchaser of the share is investing $71.13 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 54.79%.
Sales Growth
Eli Lilly and Company’s sales growth is 16.1% for the ongoing quarter and 14.7% for the next.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Eli Lilly and Company’s EBITDA is 212.65.
Dividend Yield
As stated by Morningstar, Inc., the next dividend payment is on Aug 13, 2023, the estimated forward annual dividend rate is 4.52 and the estimated forward annual dividend yield is 0.97%.
Volume
Today’s last reported volume for Eli Lilly and Company is 1769460 which is 41.31% below its average volume of 3015300.
More news about Eli Lilly and Company.
10. VerifyMe (VRME) – 3.01%
VerifyMe, Inc., together with its subsidiary, PeriShip Global, LLC, operates as a technology solutions provider that specializes in products to connect brands with consumers and providing brands with end-to-end logistics management for their products. The company operates through two segments, VerifyMe Solutions and PeriShip Global Solutions. The VerifyMe Solutions segment offers technology solutions to connect brands with consumers allowing brand owners to gather business intelligence while engaging directly with their consumers. Its solutions provide brand protection and supply chain functions, such as counterfeit prevention, traceability, consumer engagement solutions, and authentication for labels, packaging, and products, as well as tamper-proof labels. The PeriShip Global Solutions segment offers predictive analytics for optimizing delivery of time and temperature sensitive perishable products. This segment's products include PeriTrack customer dashboard, an integrated web portal tool gives its customers an in-depth look at their shipping activities based on real-time data. It also provides call center, pre-transit, post-delivery, and weather/traffic services. The company has a strategic partnership with INX International Ink Company. The company was formerly known as LaserLock Technologies, Inc. and changed its name to VerifyMe, Inc. in July 2015. VerifyMe, Inc. was incorporated in 1999 and is headquartered in Lake Mary, Florida.
NASDAQ ended the session with VerifyMe rising 3.01% to $1.37 on Friday while NASDAQ dropped 0.18% to $14,113.70.
Earnings Per Share
As for profitability, VerifyMe has a trailing twelve months EPS of $-1.67.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -88%.
More news about VerifyMe.
Losers Today
1. Canopy Growth (CGC) – -38.25%
Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and hemp-based products for recreational and medical purposes primarily in Canada, the United States, and Germany. It operates through two segments, Global Cannabis and Other Consumer Products. The company's products include dried cannabis flower, extracts and concentrates, beverages, gummies, and vapes. It offers its products under the Tweed, 7ACRES, 7ACRES Craft Collective, DOJA, Ace Valley, Quatreau, Deep Space, First + Free, Surity Pro, Spectrum Therapeutics, Vert, Tokyo Smoke, Twd, Martha Stewart CBD, DNA Genetics, BioSteel, Storz & Bickel, This Works, HiWay, Simple Stash, Whisl, and Truverra brands. The company was formerly known as Tweed Marijuana Inc. and changed its name to Canopy Growth Corporation in September 2015. Canopy Growth Corporation was incorporated in 2009 and is headquartered in Smiths Falls, Canada.
NASDAQ ended the session with Canopy Growth sliding 38.25% to $0.40 on Friday, after five sequential sessions in a row of gains. NASDAQ fell 0.18% to $14,113.70, after four successive sessions in a row of gains, on what was a somewhat bearish trend trading session today.
: canopy growth strikes agreements with lenders to delever its balance sheet by $437 million over next six monthsCanadian cannabis company Canopy Growth Corp. said Friday it has reached agreements with its lenders that will delever its balance sheet by C$437 million ($333.04 million) over the next six months.
Canopy growth strikes deal with lenders to reduce debt by $333 millionCanadian cannabis company Canopy Growth Corp. said Friday it has reached agreements with its lenders that will delever its balance sheet by C$437 million ($333.04 million) over the next six months.
Earnings Per Share
As for profitability, Canopy Growth has a trailing twelve months EPS of $-7.2.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -151.11%.
Sales Growth
Canopy Growth’s sales growth is negative 16.8% for the current quarter and negative 14.9% for the next.
More news about Canopy Growth.
2. Ericsson (ERIC) – -11.85%
Telefonaktiebolaget LM Ericsson (publ), together with its subsidiaries, provides communication infrastructure, services, and software solutions to the telecom and other sectors. It operates through four segments: Networks, Cloud Software and Services, Enterprise, and Other. The Networks segment offers radio access network solutions for various network spectrum bands, including integrated high-performing hardware and software. This segment also provides active antenna and transport solutions; and a range of service portfolio covering network deployment and support. The Cloud Software and Services segment offers core networks, business and operational support systems, network design and optimization, and network managed services. The Enterprise segment offers global communications platform including cloud-based unified communications as a service, contact center as a service, and communications platform as a service; enterprise wireless solutions comprise private wireless networks and wireless wan pre-packaged solutions; and technologies and new business solutions, such as mobile financial services, security solutions, and advertising services. The Other segment includes Redbee media that prepares and distributes live and video services for broadcasters, sports leagues, and communications service providers. It operates in North America, Europe and Latin America, the Middle East and Africa, South East Asia, Oceania, India, North East Asia, and internationally. Telefonaktiebolaget LM Ericsson (publ) was founded in 1876 and is headquartered in Stockholm, Sweden.
NASDAQ ended the session with Ericsson dropping 11.85% to $5.06 on Friday, after three successive sessions in a row of gains. NASDAQ fell 0.18% to $14,113.70, after four consecutive sessions in a row of gains, on what was a somewhat down trend exchanging session today.
Earnings Per Share
As for profitability, Ericsson has a trailing twelve months EPS of $0.48.
PE Ratio
Ericsson has a trailing twelve months price to earnings ratio of 10.54. Meaning, the purchaser of the share is investing $10.54 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 15.08%.
Volatility
Ericsson’s last week, last month’s, and last quarter’s current intraday variation average was 2.18%, 0.45%, and 1.45%.
Ericsson’s highest amplitude of average volatility was 2.18% (last week), 1.60% (last month), and 1.45% (last quarter).
Dividend Yield
As stated by Morningstar, Inc., the next dividend payment is on Mar 29, 2023, the estimated forward annual dividend rate is 0.24 and the estimated forward annual dividend yield is 4.55%.
Yearly Top and Bottom Value
Ericsson’s stock is valued at $5.06 at 17:33 EST, way under its 52-week high of $7.81 and higher than its 52-week low of $5.01.
More news about Ericsson.
3. State Street Corporation (STT) – -10.72%
State Street Corporation, through its subsidiaries, provides a range of financial products and services to institutional investors worldwide. The company offers investment servicing products and services, including custody, accounting, regulatory reporting, investor, and performance and analytics; middle office products, such as IBOR, transaction management, loans, cash, derivatives and collateral, record keeping, and client reporting and investment analytics; foreign exchange, and brokerage and other trading services; securities finance and enhanced custody products; deposit and short-term investment facilities; loans and lease financing; investment manager and alternative investment manager operations outsourcing; performance, risk, and compliance analytics; and financial data management to support institutional investors. It also engages in the provision of portfolio management and risk analytics, as well as trading and post-trade settlement services with integrated compliance and managed data. In addition, the company offers investment management strategies and products, such as core and enhanced indexing, multi-asset strategies, active quantitative and fundamental active capabilities, and alternative investment strategies. Further, it provides services and solutions, including environmental, social, and governance investing; defined benefit and defined contribution; and global fiduciary solutions, as well as exchange-traded funds under the SPDR ETF brand. The company provides its products and services to mutual funds, collective investment funds and other investment pools, corporate and public retirement plans, insurance companies, foundations, endowments, and investment managers. State Street Corporation was founded in 1792 and is headquartered in Boston, Massachusetts.
NYSE ended the session with State Street Corporation falling 10.72% to $69.16 on Friday while NYSE fell 0.41% to $16,040.23.
Earnings Per Share
As for profitability, State Street Corporation has a trailing twelve months EPS of $7.14.
PE Ratio
State Street Corporation has a trailing twelve months price to earnings ratio of 9.69. Meaning, the purchaser of the share is investing $9.69 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 10.67%.
Volume
Today’s last reported volume for State Street Corporation is 6514860 which is 142.62% above its average volume of 2685140.
Revenue Growth
Year-on-year quarterly revenue growth declined by 0.8%, now sitting on 12.1B for the twelve trailing months.
More news about State Street Corporation.
4. SmileDirectClub (SDC) – -9.76%
SmileDirectClub, Inc., an oral care company, offers clear aligner therapy treatment. The company manages the end-to-end process, which include marketing, aligner manufacturing, fulfillment, treatment by a customer's dentist or orthodontist, and facilitating remote clinical monitoring through a network of orthodontists and general dentists through its proprietary teledentistry platform, SmileCheck in the United States, Puerto Rico, Canada, Australia, the United Kingdom, New Zealand, Ireland, Hong Kong, Germany, Singapore, France, Spain, and Austria. It also offers aligners, impression and whitening kits, whitening gels, and retainers; and toothbrushes, toothpastes, water flossers, SmileSpa, and various ancillary oral care products. The company was founded in 2014 and is headquartered in Nashville, Tennessee.
NASDAQ ended the session with SmileDirectClub sliding 9.76% to $0.70 on Friday, following the last session’s upward trend. NASDAQ slid 0.18% to $14,113.70, after four sequential sessions in a row of gains, on what was a somewhat negative trend exchanging session today.
Earnings Per Share
As for profitability, SmileDirectClub has a trailing twelve months EPS of $-2.628.
Sales Growth
SmileDirectClub’s sales growth is negative 19% for the ongoing quarter and 10.8% for the next.
More news about SmileDirectClub.
5. Lumen Technologies (LUMN) – -9.47%
Lumen Technologies, Inc., a facilities-based technology and communications company, provides various integrated products and services under the Lumen, Quantum Fiber, and CenturyLink brands to business and residential customers in the United States and internationally. The company operates in two segments, Business and Mass Markets. It offers compute and application services, such as edge cloud services, IT solutions, unified communication and collaboration solutions, colocation and data center services, content delivery services, and managed security services; and IP and data services, including VPN data network, Ethernet, internet protocol (IP), and voice over internet protocol. The company also provides fiber infrastructure services comprising high bandwidth optical wavelength networks; and unlit optical fiber and related professional services. In addition, it offers voice and other services, including private line services, a direct circuit or channel specifically dedicated for connecting two or more organizational sites; a portfolio of traditional time division multiplexing voice services; and synchronous optical network-based ethernet, legacy data hosting services, and conferencing services. The company was formerly known as CenturyLink, Inc. and changed its name to Lumen Technologies, Inc. in September 2020. The company was incorporated in 1968 and is headquartered in Monroe, Louisiana.
NYSE ended the session with Lumen Technologies falling 9.47% to $1.87 on Friday, after two sequential sessions in a row of gains. NYSE dropped 0.41% to $16,040.23, after five consecutive sessions in a row of gains, on what was a somewhat negative trend trading session today.
Earnings Per Share
As for profitability, Lumen Technologies has a trailing twelve months EPS of $-1.59.
Sales Growth
Lumen Technologies’s sales growth is negative 20.5% for the ongoing quarter and negative 17.9% for the next.
More news about Lumen Technologies.
6. Nokia (NOK) – -9.08%
Nokia Oyj provides mobile, fixed, and cloud network solutions worldwide. The company operates through four segments: Network Infrastructure, Mobile Networks, Cloud and Network Services, and Nokia Technologies. It offers products and services for radio access networks and microwave radio links for transport networks, and solutions for network management, as well as network planning, optimization, network deployment, and technical support services. The company provides fixed networking solutions, such as fiber and copper-based access infrastructure, Wi-Fi in-home solutions, and cloud and virtualization services; IP networking solutions, including IP access, aggregation, and edge and core routing for residential, business, mobile, cloud, and digital industry applications, as well as software-defined WAN solutions; a portfolio of optical networks comprising portfolio coherent optical transponders, optical transport network switchers, wavelength-division multiplexers, reconfigurable optical add-drop multiplexer solutions, and optical line systems for metro access and aggregation, data center interconnect, regional, and long-haul/ultra-long-haul applications; and submarine networks. In addition, it offers cloud and network services, including core network solutions, such as voice and packet core; business applications, which covers security, automation, and monetization; cloud and cognitive services; and enterprise solutions covering private wireless and industrial automation. Further, the company provides hardware, software, and services, as well as licensing of intellectual property, including patents, technologies, and the Nokia brand. It serves communications service providers, webscales, hyperscalers, digital industries, and government. Nokia Oyj was founded in 1865 and is headquartered in Espoo, Finland.
NYSE ended the session with Nokia dropping 9.08% to $3.96 on Friday while NYSE fell 0.41% to $16,040.23.
Nokia cuts full-year net sales guidance, narrows margin outlook on weak demandCustomer spending plans are increasingly impacted by high inflation and rising interest rates along with some projects now slipping to 2024–notably in North America, Nokia said., Ahead of the company’s second-quarter earnings on July 20, Nokia also reported preliminary net sales of around EUR5.7 billion for the three-month period and a comparable operating margin of around 11%, with operating profit boosted by EUR80 million related to catch-up payments in its technologies unit.
Earnings Per Share
As for profitability, Nokia has a trailing twelve months EPS of $0.84.
PE Ratio
Nokia has a trailing twelve months price to earnings ratio of 4.71. Meaning, the purchaser of the share is investing $4.71 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 21.91%.
Dividend Yield
As stated by Morningstar, Inc., the next dividend payment is on Apr 23, 2023, the estimated forward annual dividend rate is 0.12 and the estimated forward annual dividend yield is 2.77%.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Nokia’s EBITDA is 33.91.
Growth Estimates Quarters
The company’s growth estimates for the current quarter is a negative 27.3% and positive 10% for the next.
More news about Nokia.
7. Tilray (TLRY) – -8.56%
Tilray Brands, Inc. engages in the research, cultivation, production, marketing, and distribution of medical cannabis products in Canada, the United States, Europe, Australia, New Zealand, Latin America, and internationally. The company operates through four segments: Cannabis Business, Distribution Business, Beverage Alcohol Business, and Wellness Business. It offers medical and adult-use cannabis products, including GMP-certified flowers, oils, vapes, edibles, and topicals; purchases and resells pharmaceutical and wellness products; and produces, markets, sells, and distributes beverage alcohol products, and hemp-based food and other wellness products. The company offers its products under the Tilray, Aphria, Broken Coast, Symbios, B!NGO, The Batch, P'tite Pof, Dubon, Good Supply, Solei, Chowie Wowie, Canaca, RIFF, SweetWater, Breckenridge Distillery, Alpine Beer Company, and Green Flash brands. It sells its products to retailers, wholesalers, patients, physicians, hospitals, pharmacies, researchers, and governments, as well as direct to consumers. The company was formerly known as Tilray, Inc. Tilray Brands, Inc. is headquartered in Leamington, Canada.
NASDAQ ended the session with Tilray dropping 8.56% to $1.66 on Friday, following the last session’s upward trend. NASDAQ dropped 0.18% to $14,113.70, after four successive sessions in a row of gains, on what was a somewhat bearish trend trading session today.
Earnings Per Share
As for profitability, Tilray has a trailing twelve months EPS of $-3.31.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -44.15%.
Volume
Today’s last reported volume for Tilray is 17752800 which is 17.85% above its average volume of 15063400.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Tilray’s EBITDA is -1.64.
Revenue Growth
Year-on-year quarterly revenue growth declined by 4.1%, now sitting on 596.26M for the twelve trailing months.
Moving Average
Tilray’s value is way below its 50-day moving average of $2.00 and way under its 200-day moving average of $2.81.
More news about Tilray.
8. Peloton (PTON) – -8.39%
Peloton Interactive, Inc. operates interactive fitness platform in North America and internationally. The company offers connected fitness products with touchscreen that streams live and on-demand classes under the Peloton Bike, Peloton Bike+, Peloton Tread, and Peloton Tread+ names. It also provides connected fitness subscriptions for various household users, and access to various live and on-demand classes, as well as Peloton Digital app for connected fitness subscribers to provide access to its classes. As of June 30, 2022, it had approximately 6.9 million members. The company markets and sells its interactive fitness products directly through its retail showrooms and at onepeloton.com. Peloton Interactive, Inc. was founded in 2012 and is headquartered in New York, New York.
NASDAQ ended the session with Peloton falling 8.39% to $8.80 on Friday while NASDAQ dropped 0.18% to $14,113.70.
Earnings Per Share
As for profitability, Peloton has a trailing twelve months EPS of $-7.76.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -279.85%.
Volume
Today’s last reported volume for Peloton is 6903100 which is 35.43% below its average volume of 10692200.
More news about Peloton.
9. Canaan (CAN) – -7.22%
Canaan Inc. engages in the research, design, and sale of integrated circuit (IC) final mining equipment products by integrating IC products for bitcoin mining and related components in the People's Republic of China. It is also involved in the assembly and distribution of mining equipment and spare parts. The company has operations in the United States, Australia, Kazakhstan, Hong Kong, Canada, Mainland China, Thailand, Sweden, and internationally. Canaan Inc. was founded in 2013 and is based in Singapore.
NASDAQ ended the session with Canaan dropping 7.22% to $2.95 on Friday, following the last session’s upward trend. NASDAQ fell 0.18% to $14,113.70, after four consecutive sessions in a row of gains, on what was a somewhat negative trend exchanging session today.
Earnings Per Share
As for profitability, Canaan has a trailing twelve months EPS of $-0.57.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -13.4%.
Growth Estimates Quarters
The company’s growth estimates for the current quarter is a negative 120.8% and positive 207.1% for the next.
More news about Canaan.
10. Virgin Galactic (SPCE) – -6.47%
Virgin Galactic Holdings, Inc. focuses on the development, manufacture, and operation of spaceships and related technologies for conducting commercial human spaceflight and flying commercial research and development payloads into space. It is also involved in the ground and flight testing, and post-flight maintenance of its spaceflight system vehicles. The company serves private individuals, researchers, and government agencies. Virgin Galactic Holdings, Inc. was founded in 2017 is headquartered in Las Cruces, New Mexico.
NYSE ended the session with Virgin Galactic sliding 6.47% to $3.76 on Friday while NYSE fell 0.41% to $16,040.23.
Earnings Per Share
As for profitability, Virgin Galactic has a trailing twelve months EPS of $-2.18.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -101.26%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 22.9%, now sitting on 2.38M for the twelve trailing months.
Moving Average
Virgin Galactic’s worth is under its 50-day moving average of $4.11 and way under its 200-day moving average of $4.54.
Volatility
Virgin Galactic’s last week, last month’s, and last quarter’s current intraday variation average was a positive 1.80%, a negative 0.68%, and a positive 5.25%.
Virgin Galactic’s highest amplitude of average volatility was 1.97% (last week), 8.12% (last month), and 5.25% (last quarter).
Growth Estimates Quarters
The company’s growth estimates for the current quarter is a negative 18.6% and positive 14.5% for the next.
Previous days news about Virgin Galactic
- : Virgin Galactic stock rises as company sets date for second commercial flight. According to MarketWatch on Thursday, 13 July, "Details of the Galactic 02 crew and pilots will be released at a later date, Virgin Galactic said, in a statement."
More news about Virgin Galactic.
Stay up to date with our winners and losers daily report
